Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock
1 other identifier
interventional
36
1 country
1
Brief Summary
Background: Electrical stimulation has been used in critical patients as an adjunct strategy of early rehabilitation. In septic or septic shock patients there are reports of only two studies in the literature, with conflicting results. Objective: To evaluate the effects of electrical stimulation in the prevention of muscle mass loss in patients admitted to the ICU with systemic inflammatory response syndrome (SIRS), sepsis or septic shock. Methods: This is a randomized, controlled, double-blind clinical trial. Thirty-six patients with a diagnosis of SIRS, sepsis or septic shock (including patients with sepsis due to the new coronavirus - COVID-19) will be randomly assigned to experimental group and sham group. They will be evaluated in relation to muscle mass, peripheral muscle strength and functional status. They will also be submitted to the collection of inflammatory, metabolic, damage and muscular trophism markers. Expected results: Electrical stimulation is expected to be able to prevent loss of muscle mass in patients admitted to the ICU with SIRS, sepsis or septic shock. In addition, it is expected to be able to preserve strength in this population without increasing the pro-inflammatory or metabolic response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable sepsis
Started Oct 2018
Longer than P75 for not_applicable sepsis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
October 24, 2018
CompletedFirst Posted
Study publicly available on registry
November 27, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2024
CompletedOctober 29, 2024
October 1, 2024
6.1 years
October 24, 2018
October 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Muscle mass
Cross-sectional area
8 days
Muscle mass
Thickness
8 days
Secondary Outcomes (13)
Peripheral muscle strength
8 days
Functional status
8 days
Inflammatory
5 days
Inflammatory
5 days
Inflammatory
5 days
- +8 more secondary outcomes
Study Arms (2)
Experimental Electrical Stimulation
EXPERIMENTALExperimental Electrical Stimulation for 40 minutos + conventional physiotherapy, during seven days.
Sham Electrical Stimulation
SHAM COMPARATORSham Electrical Stimulation for 40 minutes + conventional physiotherapy, during seven days.
Interventions
Experimental Electrical Stimulation (100Hz) during 40 minutes
Sham Electrical Stimulation (5Hz) during 40 minutes
Active and passive exercises, and walking.
Eligibility Criteria
You may qualify if:
- patients admitted to the ICU with a diagnosis of SIRS, sepsis or septic shock,
- aged ≥ 18 years,
- body mass index (BMI) ≤ 35 kg / m2,
- without diabetic polyneuropathy,
- without cardiac pacemaker,
- without diagnosis of neuromuscular diseases,
- absence of skin lesions.
You may not qualify if:
- heart attack,
- death.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Sírio-Libanês
São Paulo, 01308050, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Wellington Pereira dos Santos Yamaguti
Study Record Dates
First Submitted
October 24, 2018
First Posted
November 27, 2018
Study Start
October 1, 2018
Primary Completion
October 21, 2024
Study Completion
October 21, 2024
Last Updated
October 29, 2024
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share